General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. Opening Hook
Shelter Pharma closed FY26 with revenue of ₹73.13 Cr, up 44% year-on-year. Profit rose 25% to ₹9.03 Cr. By the company’s own framing, a strong year.
Then the cash flow statement walked in. Operating cash flow for FY26 came in at minus ₹12.48 Cr. Free cash flow landed at minus ₹14.07 Cr. A 44% growth year that consumed cash rather than threw it off.
Earnings per share, meanwhile, slipped from ₹6.26 to ₹5.44. Profit up, per-share earnings down — equity capital rose from ₹11.56 Cr to ₹16.61 Cr on a preference issue, so the same profit was spread over more shares.
The herbal-Ayurveda maker held its first investor call on 19 June, six decades after starting in Himmatnagar. Management spent much of it on a ₹200 Cr revenue target for FY2030. The FY26 numbers had a few things to say first.
2. At a Glance
- Revenue ₹73.13 Cr (+44%) – the top line did the heavy lifting; the cash flow statement declined the credit.
- OPM 17.39%, down from 19.89% – margins shed 250 bps while revenue was busy celebrating.
- EPS ₹5.44, down from ₹6.26 – the one number that walked backwards in a growth year.
- Operating cash flow –₹12.48 Cr – profit on the page, cash out the door.
- Working capital days 234 – the cash cycle now runs longer than three full quarters.
- Promoter holding 44.38%, down from 56.89% – management’s word for the slide is “internal structuring.”
3. Management’s Key Commentary
The CFO opened with the headline: revenue from operations “stood at 73.13 Cr, up 44% year-on-year,” management said. (The top line sprinted. The cash flow statement, ₹12.48 Cr in the red, was not informed it was a sprint.)
On the long game, the Chairman said the company is “targeting annual revenues of around INR 200.00 Cr till FY-2030.” (From ₹73 Cr, that is nearly a tripling in four years — built, by his own description, on container orders of ₹1–1.5 Cr each.)
Asked whether the target was sandbagged, management replied: “These are, I think, very actual numbers, not that conservative and not so aggressive.” (The numbers are actual. The achieving of them remains, for the moment, theoretical.)
On the promoter-stake drop, the Chairman clarified: “it was not actually a stake sale from the promoters; it was some internal structuring from our side.” (Internal structuring that moved promoter holding from 56.89% to 44.38%. Structurally.)
On the margin slide, management said the dip is “only because of the expansion mode we are in.” (Margins fell 250 bps. “Expansion” — the explanation that explains every margin, in every direction.)
Pressed on a floor, an analyst asked “It will not go below 17%, right?” — management: “We hope so, yes. Of course.” (A margin floor backed by hope and
